Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
News|Articles|May 2, 2014
- Pharmaceutical Technology-05-02-2014
- Volume 38
- Issue 5
Microscope Enables High-Resolution Materials Analysis
Microscope Enables High-Resolution Materials Analysis
The Thermo Scientific DXRxi Raman imaging microscope is designed to quickly reveal molecular structure, chemical composition, and sample morphology. The microscope can provide new insights, identify defects, and confirm product quality. By employing the new OMNIC xi image-centric software interface, users can quickly profile materials through chemical images. In addition, the DXRxi microscope can analyze large areas, providing microscopic detail in seconds.
Articles in this issue
over 12 years ago
Extractables and Leachables Testingover 12 years ago
Mass Spectrometer Enhances Performance in Protein Analysisover 12 years ago
Data Integrity in the Analytical Laboratoryover 12 years ago
Q&A with Tony Mitchell, Pharma Tech Industriesover 12 years ago
Linking Drug Shortages and Quality Metricsover 12 years ago
EU Steps Up Inspection Effortsover 12 years ago
Aggregation System Improves Analysis of Sub-Visible Particlesover 12 years ago
Boosting New Antibiotic Drug Development in Europeover 12 years ago
Freeze Drying Protein FormulationsRelated to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Trending on Pharmaceutical Technology
1
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
2
Pharma Fundamentals: Digital Pathology in Drug Development, Part 1
3
PharmTech AI Pulse Check: Validating Multi-Agent Systems, OCR Models in GxP
4
EU Clears AstraZeneca's Trixeo for Asthma, Opening New Manufacturing Demand for Single-Inhaler Triple Therapy
5